Review: rosiglitazone increases risk of MI but does not differ from other drugs for CV death in type 2 diabetes

 

作者: Mark AHlatky,   Dena MBravata,  

 

期刊: Evidence-Based Medicine  （BMJ Available online 2007）
卷期: Volume 12, issue 6  

页码: 169-170

 

ISSN:1473-6810

 

年代: 2007

 

出版商: ebm

 

数据来源: BMJ

 

 

点击下载:  PDF (144KB)

返 回